- Home
- ABEV vs IDXX Comparison
ABEV vs IDXX Comparison
Compare ABEV & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEV
- IDXX
- Stock Information
- Founded
- ABEV 1885
- IDXX 1983
- Country
- ABEV Brazil
- IDXX United States
- Employees
- ABEV N/A
- IDXX N/A
- Industry
- ABEV Beverages (Production/Distribution)
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ABEV Consumer Staples
- IDXX Health Care
- Exchange
- ABEV Nasdaq
- IDXX Nasdaq
- Market Cap
- ABEV 38.8B
- IDXX 37.9B
- IPO Year
- ABEV N/A
- IDXX 1991
- Fundamental
- Price
- ABEV $2.39
- IDXX $523.92
- Analyst Decision
- ABEV Hold
- IDXX Buy
- Analyst Count
- ABEV 3
- IDXX 8
- Target Price
- ABEV $2.60
- IDXX $546.00
- AVG Volume (30 Days)
- ABEV 28.3M
- IDXX 479.9K
- Earning Date
- ABEV 07-31-2025
- IDXX 08-05-2025
- Dividend Yield
- ABEV 1.86%
- IDXX N/A
- EPS Growth
- ABEV N/A
- IDXX 4.80
- EPS
- ABEV 0.16
- IDXX 10.82
- Revenue
- ABEV $15,989,142,713.00
- IDXX $3,931,836,000.00
- Revenue This Year
- ABEV $9.69
- IDXX $8.17
- Revenue Next Year
- ABEV $5.20
- IDXX $7.64
- P/E Ratio
- ABEV $14.96
- IDXX $48.14
- Revenue Growth
- ABEV 15.34
- IDXX 5.56
- 52 Week Low
- ABEV $1.76
- IDXX $356.14
- 52 Week High
- ABEV $2.64
- IDXX $530.73
- Technical
- Relative Strength Index (RSI)
- ABEV 40.08
- IDXX 60.15
- Support Level
- ABEV $2.42
- IDXX $513.92
- Resistance Level
- ABEV $2.48
- IDXX $530.12
- Average True Range (ATR)
- ABEV 0.05
- IDXX 8.73
- MACD
- ABEV -0.01
- IDXX -2.76
- Stochastic Oscillator
- ABEV 11.54
- IDXX 73.98
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.